Acutaas Chemicals Ltd (ACUTAAS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543349 | NSE: ACUTAAS | Pharmaceuticals & Drugs | Small Cap

Acutaas Chemicals Share Price

1,710.55 -0.55 -0.03%
as on 05-Dec'25 14:26

Acutaas Chemicals Ltd (ACUTAAS) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543349 | NSE: ACUTAAS | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Acutaas Chemicals

Based on:

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Acutaas Chemicals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
62.07
Market Cap:
14,009 Cr.
52-wk low:
919.6
52-wk high:
1,901.4

Is Acutaas Chemicals Ltd an attractive stock to invest in?

1. Is Acutaas Chemicals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Acutaas Chemicals Ltd is a good quality company.

2. Is Acutaas Chemicals Ltd undervalued or overvalued?

The key valuation ratios of Acutaas Chemicals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Acutaas Chemicals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Acutaas Chemicals Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Acutaas Chemicals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Acutaas Chemicals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 42.7%35.8%37.8%35%26.7%33.1%23.9%20.7%10.2%20%-
Value Creation
Index
2.21.71.81.50.91.40.70.5-0.30.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1541601882362403415206176889901,086
Sales YoY Gr.-4.3%17.5%25.2%1.7%42.1%52.7%18.6%11.5%44%-
Adj EPS 1.81.92.73.94.32.99.911.37.89.427.6
YoY Gr.-8%40.2%45.3%12.2%-33.8%245.1%14.5%-30.6%19.9%-
BVPS (₹) 4.46.39.212.917.18.771.180.591.280.1173
Adj Net
Profit
1111.916.724.327.254.171.982.457.8154226
Cash Flow from Ops. 10.128.81021.827.326.9-9.755.7101116-
Debt/CF from Ops. 2.90.94.42.52.25.1-0.10.120.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 23%32.8%23.9%44%
Adj EPS 20.5%16.8%-1.6%19.9%
BVPS38.2%36.1%4.1%-12.2%
Share Price - - 51.2% 52.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
52.235.734.434.928.839.821.114.99.215.521.8
Op. Profit
Mgn %
11.814.416.218.217.523.820.22015.722.827.5
Net Profit
Mgn %
7.27.48.910.311.415.913.813.48.415.620.8
Debt to
Equity
1.10.70.80.70.60.8000.300
Working Cap
Days
137150148164188181195224240200113
Cash Conv.
Cycle
38303036525672901078783

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 21.80%

Sales growth is growing at healthy rate in last 3 years 23.92%

Sales growth is good in last 4 quarters at 37.87%

Net Profit has been subdued in last 3 years -1.61%

Latest Financials - Acutaas Chemicals Ltd.

Standalone Consolidated
TTM EPS (₹) 27.6 27.4
TTM Sales (₹ Cr.) 1,086 1,097
BVPS (₹.) 173 172.7
Reserves (₹ Cr.) 1,376 1,373
P/BV 9.89 9.91
PE 62.07 62.55
From the Market
52 Week Low / High (₹) 919.63 / 1901.35
All Time Low / High (₹) 382.07 / 1901.35
Market Cap (₹ Cr.) 14,009
Equity (₹ Cr.) 40.9
Face Value (₹) 5
Industry PE 40.7

Management X-Ray of Acutaas Chemicals:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Acutaas Chemicals - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Acutaas Chemicals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales154160188236240341520617688990
Operating Expenses 136137158193199260415494580765
Manufacturing Costs16162121394671697381
Material Costs9195113149129180273331408548
Employee Cost 771011182141496181
Other Costs 21181411131430453854
Operating Profit 182331434180105123108225
Operating Profit Margin (%) 11.8%14.4%16.2%18.2%17.1%23.5%20.2%19.9%15.7%22.7%
Other Income 303131341418
Interest 3335666266
Depreciation 11234410121524
Exceptional Items 00000000-320
Profit Before Tax 1819283735729111269214
Tax 57101271820292554
Profit After Tax 131218252754728344160
PAT Margin (%) 8.2%7.5%9.8%10.5%11.5%15.9%13.8%13.5%6.4%16.1%
Adjusted EPS (₹)2.01.92.93.94.42.99.911.45.99.7
Dividend Payout Ratio (%)0%0%0%0%0%0%15%13%25%8%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 273958811081645185876731,311
Share Capital 22211113236363741
Reserves 26385671971324825506361,271
Minority Interest0000000000
Debt2723414854117131726
Long Term Debt161431222073101140
Short Term Debt119926344503596
Trade Payables283848695185118139133156
Others Liabilities 88914154418309365
Total Liabilities 911091552122284106557591,0711,538

Fixed Assets

Gross Block1522247075177204261410577
Accumulated Depreciation681012131727395377
Net Fixed Assets 915155862161178222357499
CWIP 411302120330125130
Investments 11152128283333336870
Inventories202027395260112119151174
Trade Receivables3636507353119162230213289
Cash Equivalents 131032995932241
Others Assets 118111218366866125135
Total Assets 911091552122284106557591,0711,538

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 102910222727-1056101116
PBT 1819283735729111269214
Adjustment 34457912114215
Changes in Working Capital -713-15-6-7-40-91-436-69
Tax Paid -3-7-8-14-8-14-23-24-16-44
Cash Flow From Investing Activity -14-19-27-25-24-101-122-20-337-234
Capex -3-15-21-17-19-102-33-84-306-191
Net Investments -11-4-6-8-51-9261-40-54
Others 00000032910
Cash Flow From Financing Activity 4-7143072140-14235274
Net Proceeds from Shares 000000300052499
Net Proceeds from Borrowing 10-117-900-1362113-114
Interest Paid -2-3-3-4-5-5-5-2-6-6
Dividend Paid 0000000-11-11-12
Others -3-2017677-18-387-94
Net Cash Flow -02-2-03-2821-1155

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)59.8336.0737.9435.4529.0639.7221.115.096.9416.08
ROCE (%)42.7335.837.7635.0226.6833.0523.8820.6710.2219.99
Asset Turnover Ratio2.051.61.421.281.091.070.980.870.750.76
PAT to CFO Conversion(x)0.772.420.560.8810.5-0.140.672.30.73
Working Capital Days
Receivable Days7283849595929811611893
Inventory Days40454651696061687260
Payable Days9712813914217013813614212296

Acutaas Chemicals Ltd Stock News

Acutaas Chemicals Ltd FAQs

The current trading price of Acutaas Chemicals on 05-Dec-2025 14:26 is ₹1,710.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Acutaas Chemicals stood at ₹14,009.
The latest P/E ratio of Acutaas Chemicals as of 04-Dec-2025 is 62.07.
The latest P/B ratio of Acutaas Chemicals as of 04-Dec-2025 is 9.89.
The 52-week high of Acutaas Chemicals is ₹1,901.4 and the 52-week low is ₹919.6.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Acutaas Chemicals is ₹1,086 ( Cr.) .

About Acutaas Chemicals Ltd

Ami Organics is a research and development (R&D) driven manufacturer of specialty chemicals with varied end usage, focused towards the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates) for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals, especially from its recent acquisition of the business of Gujarat Organics (GOL) (Acquisition). The company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Pharma Intermediates which it manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and globally.

The company has developed and commercialized over 450 Pharma Intermediates for APIs across 17 key therapeutic areas since inception and NCE, with a strong focus on R&D across select high-growth high margin therapeutic areas such as anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, for use across the global pharmaceutical market. In addition, the company recently completed the acquisition of two additional manufacturing facilities operated by GOL which has added preservatives (parabens and parabens formulations which have end usage in cosmetics, animal food and personal care industries) and other specialty chemicals (with end usage in inter alia the cosmetics, dyes polymers and agrochemicals industries) in its existing product portfolio, which command significant market share globally in the supply of certain paraben derivatives. The acquisition is in line with company’s inorganic growth strategy of foraying further into the specialty chemicals sector and it will enable it to significantly diversify its existing product portfolio, with an objective of attaining inorganic expansion of its business.

Business area of the company

The company is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

Awards, accreditations or recognitions

  • 2005: Gujarat Gas Safety Award for developing and implementing effective HSE Management System by Gujarat Gas Company Limited.
  • 2016: Obtained certifications for ISO 9001:2015 and ISO 14001:2015.
  • 2017: Outstanding export performance “Second Award” under the category of Panel - II: Inorganic, Organic and Agro Chemicals - (SSM) for the year 2016-17.
  • 2018: Conferred the title of the “Best Recuiter” by Uka Tarsadia University, Bardoli.
  • 2018: Recognition by the Directorate General of Foreign Trade with status of ‘Two Star Export House’.
  • 2018: Certified by the Central Board of Indirect Taxes and Customs as ‘Authorised Economic Operator’ in recognition and appreciation of Company’s commitment to secure international supply chain and compliance with ‘WCO’s SAFE Framework of Standards’.
  • 2018: Obtained certification for SA 8000:2014.
  • 2018: “Business Innovation Award” under Dare to Dream awards by SAP.
  • 2019: Obtained certification for ISO 45001:2018.
  • 2021: Award for Excellence in the ‘Research in Science & Technology’ category by the Federation of Gujarat Industries.
  • 2021: Fairdeal Filaments Awards for Outstanding Entrepreneur in MSME Segment by the Southern Gujarat Chamber of Commerce & Industry.

Major events and milestones

  • 2004: Formation of partnership firm in the name of “Ami Organics”.
  • 2007: Ami Organics changed its constitution into Ami Organics Private Limited.
  • 2011: Implemented the Integrated Management System (IMS).
  • 2015: Achieved turnover of Rs 1,000 million.
  • 2015: Incorporated Ami Onco-Theranostics, LLC in USA along with Photolitec LLC.
  • 2016: Established a tertiary effluent treatment plant to become zero liquid discharge plant.
  • 2016: Received recognition from the Department of Scientific and Industrial Research for company's in-house research and development (R&D) unit.
  • 2017: Increased warehouse capacity by establishing a warehouse equipped with modern infrastructure including fire and safety and having a storage capacity of 1050 metric ton (MT) of raw material.
  • 2017: Achieved turnover of Rs 1,500 million.
  • 2017: Applied for process patents for five products in India.
  • 2018: Completed assessment of and established a good manufacturing practice (GMP) compliant facility at company’s production site and warehouse in Surat, Gujarat.
  • 2018: Applied for process patents for three additional products in India.
  • 2018: Converted Ami Organics Private Limited into a public limited company, Ami Organics Limited.
  • 2018: Received first establishment inspection report (“EIR”) from the United States Food and Drug Administration (“USFDA”).
  • 2020: Received second EIR from USFDA for the manufacturing facility at Surat, Gujarat.
  • 2020: Commencement of a new research and development laboratory at Sachin, Surat, Gujarat.
  • 2020: Commencement of the new solvent recovery plant at Sachin, Surat, Gujarat.
  • 2021: Acquisition of the Ankleshwar and Jhagadia units from Gujarat Organics Limited.
  • 2021: Applied for process patents for three additional products in India.


You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×